These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7678805)

  • 1. Synthesis and assembly of functionally active human vascular endothelial growth factor homodimers in insect cells.
    Fiebich BL; Jäger B; Schöllmann C; Weindel K; Wilting J; Kochs G; Marmé D; Hug H; Weich HA
    Eur J Biochem; 1993 Jan; 211(1-2):19-26. PubMed ID: 7678805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and characterization of human vascular endothelial growth factor (VEGF165) in insect cells.
    Lee GY; Jung WW; Kang CS; Bang IS
    Protein Expr Purif; 2006 Apr; 46(2):503-9. PubMed ID: 16289914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disulfide structure of the heparin binding domain in vascular endothelial growth factor: characterization of posttranslational modifications in VEGF.
    Keck RG; Berleau L; Harris R; Keyt BA
    Arch Biochem Biophys; 1997 Aug; 344(1):103-13. PubMed ID: 9244387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency.
    Keyt BA; Berleau LT; Nguyen HV; Chen H; Heinsohn H; Vandlen R; Ferrara N
    J Biol Chem; 1996 Mar; 271(13):7788-95. PubMed ID: 8631822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solution structure of the heparin-binding domain of vascular endothelial growth factor.
    Fairbrother WJ; Champe MA; Christinger HW; Keyt BA; Starovasnik MA
    Structure; 1998 May; 6(5):637-48. PubMed ID: 9634701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in vivo bioactivity of vascular endothelial growth factor/vascular permeability factor is independent of N-linked glycosylation.
    Walter DH; Hink U; Asahara T; Van Belle E; Horowitz J; Tsurumi Y; Vandlen R; Heinsohn H; Keyt B; Ferrara N; Symes JF; Isner JM
    Lab Invest; 1996 Feb; 74(2):546-56. PubMed ID: 8780172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel method to purify recombinant vascular endothelial growth factor (VEGF121) expressed in yeast.
    Mohanraj D; Olson T; Ramakrishnan S
    Biochem Biophys Res Commun; 1995 Oct; 215(2):750-6. PubMed ID: 7488018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosylation of vascular endothelial growth factor is not required for its mitogenic activity.
    Peretz D; Gitay-Goren H; Safran M; Kimmel N; Gospodarowicz D; Neufeld G
    Biochem Biophys Res Commun; 1992 Feb; 182(3):1340-7. PubMed ID: 1540178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of biologically active human vascular endothelial growth factor in yeast.
    Mohanraj D; Olson T; Ramakrishnan S
    Growth Factors; 1995; 12(1):17-27. PubMed ID: 8527160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms.
    Houck KA; Leung DW; Rowland AM; Winer J; Ferrara N
    J Biol Chem; 1992 Dec; 267(36):26031-7. PubMed ID: 1464614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of biologically active isoforms of the tumor angiogenesis factor VEGF in Escherichia coli.
    Siemeister G; Schnurr B; Mohrs K; Schächtele C; Marmé D; Martiny-Baron G
    Biochem Biophys Res Commun; 1996 May; 222(2):249-55. PubMed ID: 8670191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural requirements for dimerization, glycosylation, secretion, and biological function of VPF/VEGF.
    Claffey KP; Senger DR; Spiegelman BM
    Biochim Biophys Acta; 1995 Jan; 1246(1):1-9. PubMed ID: 7811723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo.
    Zhang HT; Scott PA; Morbidelli L; Peak S; Moore J; Turley H; Harris AL; Ziche M; Bicknell R
    Br J Cancer; 2000 Jul; 83(1):63-8. PubMed ID: 10883669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules.
    Gitay-Goren H; Soker S; Vlodavsky I; Neufeld G
    J Biol Chem; 1992 Mar; 267(9):6093-8. PubMed ID: 1556117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High levels of biologically active vascular endothelial growth factor (VEGF) are produced by the baculovirus expression system.
    Cohen T; Gitay-Goren H; Neufeld G; Levi BZ
    Growth Factors; 1992; 7(2):131-8. PubMed ID: 1419070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.
    Meyer M; Clauss M; Lepple-Wienhues A; Waltenberger J; Augustin HG; Ziche M; Lanz C; Büttner M; Rziha HJ; Dehio C
    EMBO J; 1999 Jan; 18(2):363-74. PubMed ID: 9889193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells.
    Zhang HT; Craft P; Scott PA; Ziche M; Weich HA; Harris AL; Bicknell R
    J Natl Cancer Inst; 1995 Feb; 87(3):213-9. PubMed ID: 7535859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA.
    Houck KA; Ferrara N; Winer J; Cachianes G; Li B; Leung DW
    Mol Endocrinol; 1991 Dec; 5(12):1806-14. PubMed ID: 1791831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta.
    Hauser S; Weich HA
    Growth Factors; 1993; 9(4):259-68. PubMed ID: 8148155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleotide sequence and expression of the feline vascular endothelial growth factor.
    Koga L; Kobayashi Y; Yazawa M; Maeda S; Masuda K; Ohno K; Tsujimoto H
    J Vet Med Sci; 2002 May; 64(5):453-6. PubMed ID: 12069081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.